JSP Pharmaceutical Manufacturing (Thailand) Public Co., Ltd. (BKK:JSP)
Thailand · Delayed Price · Currency is THB 1.740
-0.010 (-0.57%)
Sep 3, 2026, 12:21 PM ICT
BKK:JSP Financials Overview
Financials in millions THB. Fiscal year is January - December.
Millions THB. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 992.08 | 1,043 | 845.93 | 594.36 | 466.8 | 429.13 |
Revenue Growth | 0.79% | 23.26% | 42.33% | 27.32% | 8.78% | -7.27% |
Gross Profit Gross Profit Growth | 402.35 | 438.01 | 326.44 | 162.3 | 153.69 | 151.15 |
Operating Income Operating Income Growth | 80.76 | 109.68 | 102.35 | -0.41 | -1.07 | 48.3 |
Net Income Net Income Growth | 42.92 | 67.87 | 4.52 | -1.72 | -17.48 | 29.69 |
Earnings Per Share EPS Growth | 0.08 | 0.14 | 0.01 | -0.00 | -0.04 | 0.08 |
EPS Growth | 29.38% | 1368.43% | - | - | - | -13.70% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Manufacture and Sell of Products under Customers' Brand Name (OEM) Manufacture and Sell of Products under Customers' Brand Name (OEM) Growth | 331.43 | 352.96 | 308.39 | 288.49 | 249.38 | 274.2 |
Manufacture and Sell of Products under The Company's Brand Name (Own Brand) Manufacture and Sell of Products under The Company's Brand Name (Own Brand) Growth | 376.7 | 419.62 | 337.2 | 192.74 | 168.91 | 139.95 |
Hemodialysis Hemodialysis Growth | 193.99 | 184.74 | 140.03 | 64.67 | - | - |
Research Research Growth | 22.39 | 15.8 | 8.04 | 7.74 | 29.19 | - |
Others Others Growth | 32.52 | 37.1 | 30.84 | 21.95 | 10.6 | 8.19 |
Unallocated Revenues Unallocated Revenues Growth | 35.05 | 32.46 | 21.45 | 18.78 | 8.73 | 6.79 |
Total Total Growth | 992.08 | 1,043 | 845.93 | 594.36 | 466.81 | 429.13 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 42.84 | 48.03 | 29.49 | 20.65 | 310.01 | 650.9 |
Total Debt Total Debt Growth | 388.03 | 381.17 | 288.41 | 290.53 | 189.12 | 183.45 |
Net Cash (Debt) Net Cash Growth | -345.19 | -333.14 | -258.92 | -269.88 | 120.89 | 467.46 |
Net Cash Growth | - | - | - | - | -74.14% | - |
Net Cash Per Share Net Cash Per Share Growth | -0.67 | -0.70 | -0.55 | -0.58 | 0.25 | 1.30 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 117.85 | 130.93 | 132.12 | 40.35 | 2.81 | 51.72 |
Capital Expenditures CapEx Growth | -278.05 | -279.27 | -56.42 | -172.89 | -288.7 | -36.55 |
Free Cash Flow Free Cash Flow Growth | -160.2 | -148.33 | 75.69 | -132.55 | -285.89 | 15.17 |
Free Cash Flow Growth | - | - | - | - | - | -60.93% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 40.56% | 42.01% | 38.59% | 27.31% | 32.92% | 35.22% |
Operating Margin | 8.14% | 10.52% | 12.10% | -0.07% | -0.23% | 11.25% |
Pretax Margin | 7.20% | 9.59% | -3.94% | 0.92% | -3.38% | 8.72% |
Profit Margin | 4.33% | 6.51% | 0.53% | -0.29% | -3.74% | 6.92% |
FCF Margin | -16.15% | -14.23% | 8.95% | -22.30% | -61.25% | 3.54% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 3, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Dividend Per Share Dividend Per Share Growth | 0.042 | 0.100 | 0.032 | - | - | 0.013 |
Dividend Per Share Growth | 30.42% | 216.46% | - | - | - | - |
Dividend Yield | 2.45% | 5.46% | 1.67% | - | - | 0.19% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 3, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 21.88 | 13.29 | 211.87 | - | - | 113.40 |
P/FCF Ratio | - | - | 12.67 | - | - | 221.88 |
PS Ratio | 0.84 | 0.87 | 1.13 | 1.84 | 3.53 | 7.85 |